|
HY-100302-1mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-10mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-100mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-25mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-5mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-50mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264-10mg
|
MedChemexpress LLC
|
Edoxaban [CAS 480449-70-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264-100mg
|
MedChemexpress LLC
|
Edoxaban [CAS 480449-70-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264-5mg
|
MedChemexpress LLC
|
Edoxaban [CAS 480449-70-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264-50mg
|
MedChemexpress LLC
|
Edoxaban [CAS 480449-70-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264A-10mg
|
MedChemexpress LLC
|
Edoxaban (tosylate) [CAS 480449-71-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264A-5mg
|
MedChemexpress LLC
|
Edoxaban (tosylate) [CAS 480449-71-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264B-10mg
|
MedChemexpress LLC
|
Edoxaban (tosylate monohydrate) [CAS 1229194-11-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264B-100mg
|
MedChemexpress LLC
|
Edoxaban (tosylate monohydrate) [CAS 1229194-11-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264B-5mg
|
MedChemexpress LLC
|
Edoxaban (tosylate monohydrate) [CAS 1229194-11-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264B-50mg
|
MedChemexpress LLC
|
Edoxaban (tosylate monohydrate) [CAS 1229194-11-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-106994-10mg
|
MedChemexpress LLC
|
Nebentan [CAS 403604-85-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-106994-25mg
|
MedChemexpress LLC
|
Nebentan [CAS 403604-85-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-106994-5mg
|
MedChemexpress LLC
|
Nebentan [CAS 403604-85-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-108632-1mg
|
MedChemexpress LLC
|
BYK204165 [CAS 1104546-89-5]
|
|
Cancer-programmed cell death
|
|
|
HY-108632-10mg
|
MedChemexpress LLC
|
BYK204165 [CAS 1104546-89-5]
|
|
Cancer-programmed cell death
|
|
|
HY-108632-25mg
|
MedChemexpress LLC
|
BYK204165 [CAS 1104546-89-5]
|
|
Cancer-programmed cell death
|
|
|
HY-108632-5mg
|
MedChemexpress LLC
|
BYK204165 [CAS 1104546-89-5]
|
|
Cancer-programmed cell death
|
|
|
HY-112038-1mg
|
MedChemexpress LLC
|
GSK2983559 (free acid) [CAS 1579965-12-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-112038-10mg
|
MedChemexpress LLC
|
GSK2983559 (free acid) [CAS 1579965-12-0]
|
|
COVID-19-immunoregulation
|
|
